Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.
Chimonas T, Athyros VG, Ganotakis E, Nicolaou V, Panagiotakos DB, Mikhailidis DP, Elisaf M; Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT) Collaborative Group. Chimonas T, et al. Among authors: mikhailidis dp. Angiology. 2010 Feb-Mar;61(1):49-57. doi: 10.1177/0003319709351873. Angiology. 2010. PMID: 20034959
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, Calvaruso V, Mikhailidis DP, Dhillon AP, Burroughs AK. Manousou P, et al. Among authors: mikhailidis dp. Liver Int. 2011 May;31(5):730-9. doi: 10.1111/j.1478-3231.2011.02488.x. Epub 2011 Mar 6. Liver Int. 2011. PMID: 21457446 Free article.
Liver enzymes: potential cardiovascular risk markers?
Lioudaki E, Ganotakis ES, Mikhailidis DP. Lioudaki E, et al. Among authors: mikhailidis dp. Curr Pharm Des. 2011 Nov;17(33):3632-43. doi: 10.2174/138161211798220945. Curr Pharm Des. 2011. PMID: 22074433 Review.
The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.
Athyros VG, Tziomalos K, Katsiki N, Gossios TD, Giouleme O, Anagnostis P, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP; GREACE Study Collaborative Group. Athyros VG, et al. Among authors: mikhailidis dp. Curr Vasc Pharmacol. 2013 Sep;11(5):779-84. doi: 10.2174/1570161111311050016. Curr Vasc Pharmacol. 2013. PMID: 23140546 Clinical Trial.
Are statins 'IDEAL' for non-alcoholic fatty liver disease?
Athyros VG, Katsiki N, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Among authors: mikhailidis dp. Curr Med Res Opin. 2014 Feb;30(2):229-31. doi: 10.1185/03007995.2013.855192. Epub 2013 Oct 28. Curr Med Res Opin. 2014. PMID: 24127654
Psoriasis and Vascular Risk : An Update.
Katsiki N, Anagnostis P, Athyros VG, Karagiannis A, Mikhailidis DP. Katsiki N, et al. Among authors: mikhailidis dp. Curr Pharm Des. 2014;20(39):6114-25. doi: 10.2174/1381612820666140417105323. Curr Pharm Des. 2014. PMID: 24745923 Review.
1,408 results